Mondobiotech Holding AG Basel

Mondobiotech Holding AG Baselhttps://investorshangout.com/Mondobiotech-Holding-AG-Basel-RLFTF-93839/en-usMon, 19 Oct 2026 21:01:21 GMTCopyright InvestorsHangout.comswordman: DR discussion on use https://youtu.be/xLv4uk40h7Uhttps://investorshangout.com/post/view?id=6580091https://investorshangout.com/post/view?id=6580091Mon, 29 May 2023 20:52:17 GMTswordman: So mine showed today in Fidelity acctshttps://investorshangout.com/post/view?id=6572258https://investorshangout.com/post/view?id=6572258Mon, 08 May 2023 23:02:11 GMTFlash08: Never got my new shares? What is going on?https://investorshangout.com/post/view?id=6572080https://investorshangout.com/post/view?id=6572080Mon, 08 May 2023 16:42:06 GMTswordman: Annual meeting shareholder results https://relieftherapeutics.com/newsblog-detail/?newsID=2501905https://investorshangout.com/post/view?id=6568124https://investorshangout.com/post/view?id=6568124Fri, 28 Apr 2023 18:19:32 GMTswordman: Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparatihttps://investorshangout.com/post/view?id=6567656https://investorshangout.com/post/view?id=6567656Thu, 27 Apr 2023 23:03:40 GMTswordman: https://relieftherapeutics.com/newsblog-detail/?newsID=2489719https://investorshangout.com/post/view?id=6561475https://investorshangout.com/post/view?id=6561475Sat, 15 Apr 2023 04:49:15 GMTFlash08: Reverse split- 400-1 Thoughts? https://investorshangout.com/post/view?id=6556393https://investorshangout.com/post/view?id=6556393Tue, 04 Apr 2023 09:47:13 GMTFlash08: Looks like they can sell in the US. Great news!!https://investorshangout.com/post/view?id=6542551https://investorshangout.com/post/view?id=6542551Tue, 28 Feb 2023 14:30:16 GMTswordman: https://simplywall.st/stocks/ch/pharmaceuticals-biotech/vtx-rlf/relief-therapeutics-holding-shares/nhttps://investorshangout.com/post/view?id=6537439https://investorshangout.com/post/view?id=6537439Thu, 16 Feb 2023 05:40:57 GMTswordman: https://pharmaceutical-journal.com/article/feature/everything-you-need-to-know-about-the-covid-19-thhttps://investorshangout.com/post/view?id=6530745https://investorshangout.com/post/view?id=6530745Thu, 02 Feb 2023 04:16:05 GMTswordman: Follow up to the use/approval in India https://youtu.be/byLnmgqGisYhttps://investorshangout.com/post/view?id=6528765https://investorshangout.com/post/view?id=6528765Sat, 28 Jan 2023 19:19:34 GMTswordman: https://relieftherapeutics.com/newsblog-detail/?newsID=2425827https://investorshangout.com/post/view?id=6528764https://investorshangout.com/post/view?id=6528764Sat, 28 Jan 2023 19:18:21 GMTswordman: Valuation https://www.relieftherapeutics.com/images/vL_Relief_Therapeutics_Valuation_Report_27DEChttps://investorshangout.com/post/view?id=6524285https://investorshangout.com/post/view?id=6524285Wed, 18 Jan 2023 21:55:43 GMTswordman: https://www.relieftherapeutics.com/newsblog-detail/?newsID=2425827&fbclid=IwAR30LzNyLWNHbhnXfYU955Fvhttps://investorshangout.com/post/view?id=6524284https://investorshangout.com/post/view?id=6524284Wed, 18 Jan 2023 21:55:04 GMTswordman: New CEO !!!!!!!!!!!!!!! https://relieftherapeutics.com/newsblog-detail/?newsID=2399619&fbclihttps://investorshangout.com/post/view?id=6508930https://investorshangout.com/post/view?id=6508930Thu, 08 Dec 2022 21:38:00 GMTznewcar1: $RLFTF 27% v1,6M c.032975 f4,192B H.0338 ML.0216https://investorshangout.com/post/view?id=6495228https://investorshangout.com/post/view?id=6495228Tue, 08 Nov 2022 03:30:52 GMTswordman: https://journals.lww.com/ccmjournal/Fulltext/2022/11000/The_Use_of_IV_Vasoactive_Intestinal_Peptide.https://investorshangout.com/post/view?id=6484874https://investorshangout.com/post/view?id=6484874Fri, 14 Oct 2022 04:17:24 GMTFlash08: What is the expected market worldwide for this product? Also, what is the status of the arbitration?https://investorshangout.com/post/view?id=6484248https://investorshangout.com/post/view?id=6484248Wed, 12 Oct 2022 20:53:22 GMTswordman: First sale of PKU Golike® in the U.S. through Relief's exclusive national distributor https://whttps://investorshangout.com/post/view?id=6482580https://investorshangout.com/post/view?id=6482580Mon, 10 Oct 2022 05:42:54 GMTswordman: https://medicaldialogues.in/critical-care/news/iv-vasoactive-intestinal-peptide-improves-survival-frhttps://investorshangout.com/post/view?id=6478654https://investorshangout.com/post/view?id=6478654Fri, 30 Sep 2022 04:45:51 GMTswordman: https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-022-06723-whttps://investorshangout.com/post/view?id=6474401https://investorshangout.com/post/view?id=6474401Thu, 22 Sep 2022 03:50:20 GMTswordman: Movin on up Weezie!!!!~ https://www.relieftherapeutics.com/newsblog-detail/?newsID=2327971https://investorshangout.com/post/view?id=6460385https://investorshangout.com/post/view?id=6460385Wed, 24 Aug 2022 22:31:34 GMTswordman: ACER gets orphan drug status https://www.relieftherapeutics.com/newsblog-detail/?newsID=2320831https://investorshangout.com/post/view?id=6453598https://investorshangout.com/post/view?id=6453598Fri, 12 Aug 2022 19:51:56 GMTswordman: Movin' on up https://newsfilter.io/a/6527834697e81ee33dbbfc5f92ee02a4https://investorshangout.com/post/view?id=6441018https://investorshangout.com/post/view?id=6441018Thu, 21 Jul 2022 05:49:16 GMTswordman: https://pajhwok.com/ps/2022/06/26/physicians-optadil-is-not-a-specific-treatment-for-coronary-heart-https://investorshangout.com/post/view?id=6428311https://investorshangout.com/post/view?id=6428311Mon, 27 Jun 2022 04:59:19 GMTswordman: New Dr Joey video https://youtu.be/aze1PPxema0https://investorshangout.com/post/view?id=6420777https://investorshangout.com/post/view?id=6420777Tue, 14 Jun 2022 02:53:18 GMTswordman: Corp update https://www.onenewspage.com/n/Press+Releases/1zobr6oq7m/Relief-Provides-Corporate-Updhttps://investorshangout.com/post/view?id=6412877https://investorshangout.com/post/view?id=6412877Tue, 31 May 2022 17:04:08 GMTswordman: Relief Therapeutics Expands U.S. Commercial Team https://relieftherapeutics.com/newsblog-detailhttps://investorshangout.com/post/view?id=6408045https://investorshangout.com/post/view?id=6408045Mon, 23 May 2022 06:29:15 GMTswordman: Dr Harris asking Fauci to PLEASE get a severe2critical therapeutic--From 11 MAY 2022 Congress testimhttps://investorshangout.com/post/view?id=6401246https://investorshangout.com/post/view?id=6401246Thu, 12 May 2022 05:48:21 GMTswordman: ANNUAL MEETING Info https://relieftherapeutics.com/newsblog-detail/?newsID=2252361https://investorshangout.com/post/view?id=6397634https://investorshangout.com/post/view?id=6397634Fri, 06 May 2022 05:52:55 GMTswordman: Proven Pharmaceutical Marketing Leader Brings Extensive Experience in Rare Diseases, Digital Innovathttps://investorshangout.com/post/view?id=6390646https://investorshangout.com/post/view?id=6390646Tue, 26 Apr 2022 18:03:43 GMTswordman: Partner files for BTD https://relieftherapeutics.com/newsblog-detail/?newsID=2241005https://investorshangout.com/post/view?id=6387955https://investorshangout.com/post/view?id=6387955Fri, 22 Apr 2022 06:37:59 GMTswordman: https://www.relieftherapeutics.com/newsblog-detail/?newsID=2235035https://investorshangout.com/post/view?id=6381621https://investorshangout.com/post/view?id=6381621Tue, 12 Apr 2022 05:31:47 GMTswordman: Relief Reports Full-Year 2021 Results and Provides Corporate Update https://newsfilter.io/a/fb3https://investorshangout.com/post/view?id=6373808https://investorshangout.com/post/view?id=6373808Thu, 31 Mar 2022 06:18:06 GMTswordman: Trademark Reg https://relieftherapeutics.com/newsblog-detail/?newsID=2221681https://investorshangout.com/post/view?id=6369058https://investorshangout.com/post/view?id=6369058Thu, 24 Mar 2022 06:27:35 GMTswordman: Preparing to Convert Relief's Level 1 American Depositary Receipt ("ADR") program in the United Stahttps://investorshangout.com/post/view?id=6366685https://investorshangout.com/post/view?id=6366685Mon, 21 Mar 2022 07:04:10 GMTswordman: U S market planning https://www.stocktitan.net/news/RLFTF/relief-therapeutics-appoints-christophehttps://investorshangout.com/post/view?id=6366683https://investorshangout.com/post/view?id=6366683Mon, 21 Mar 2022 07:01:56 GMTswordman: Subsidiary news: https://www.accesswire.com/viewarticle.aspx?id=693092https://investorshangout.com/post/view?id=6363491https://investorshangout.com/post/view?id=6363491Wed, 16 Mar 2022 03:42:07 GMTswordman: Dr story about being saved by Avip/Zyesami 2 years ago. Story published 2 months ago. Still wants EUhttps://investorshangout.com/post/view?id=6361578https://investorshangout.com/post/view?id=6361578Sun, 13 Mar 2022 23:57:13 GMTswordman: ANOTHER article--getting traction https://amgreatness.com/2022/03/09/in-letter-to-fda-and-niaid-rhttps://investorshangout.com/post/view?id=6359529https://investorshangout.com/post/view?id=6359529Thu, 10 Mar 2022 04:52:58 GMTswordman: Same story covered in Wisconsin Politics article https://www.wispolitics.com/2022/u-s-sen-johnsonhttps://investorshangout.com/post/view?id=6359474https://investorshangout.com/post/view?id=6359474Thu, 10 Mar 2022 01:04:44 GMTswordman: Text of letter: March 3, 2022 Robert M. Califf, M.D. Commissioner U.S. Food and Drug Ahttps://investorshangout.com/post/view?id=6358546https://investorshangout.com/post/view?id=6358546Tue, 08 Mar 2022 23:21:54 GMTswordman: Congress asking about Aviptadil https://www.theblaze.com/op-ed/horowitz-sen-johnson-calls-out-thttps://investorshangout.com/post/view?id=6358499https://investorshangout.com/post/view?id=6358499Tue, 08 Mar 2022 21:23:09 GMTswordman: Trial update and presentation https://www.nrxpharma.com/ceo-update-zyesami-clinical-trial-resulhttps://investorshangout.com/post/view?id=6354037https://investorshangout.com/post/view?id=6354037Tue, 01 Mar 2022 19:59:46 GMTswordman: VERY detailed financial forecast of RLFT This is a PDF download https://s33569fc90c7564f1.jimchttps://investorshangout.com/post/view?id=6348369https://investorshangout.com/post/view?id=6348369Mon, 21 Feb 2022 18:37:11 GMTswordman: SYNAIRGEN --" did not meet its primary or key secondary efficacy endpoints" Their inhaled covid druhttps://investorshangout.com/post/view?id=6348364https://investorshangout.com/post/view?id=6348364Mon, 21 Feb 2022 18:05:25 GMTswordman: And then there was 1 https://www.nrxpharma.com/nrx-pharmaceuticals-announces-us-national-instituthttps://investorshangout.com/post/view?id=6344315https://investorshangout.com/post/view?id=6344315Tue, 15 Feb 2022 16:07:37 GMTswordman: https://biobuzz.io/nrx-aims-to-bring-zyesami-to-market-based-on-real-world-data-in-treating-seriouslhttps://investorshangout.com/post/view?id=6343808https://investorshangout.com/post/view?id=6343808Mon, 14 Feb 2022 23:36:33 GMTswordman: Partner responds https://www.nrxpharma.com/nrx-responds-to-reliefs-allegations-of-january-14-2022https://investorshangout.com/post/view?id=6342985https://investorshangout.com/post/view?id=6342985Mon, 14 Feb 2022 07:36:54 GMTswordman: Lifesaving COVID Medications Can Be Hard to Come By--know where there is 1 you can use https://https://investorshangout.com/post/view?id=6342922https://investorshangout.com/post/view?id=6342922Mon, 14 Feb 2022 00:21:10 GMT